FDA Alerts

The FDA has expanded the approval of a drug to include the treatment of adults with lower limb spasticity.

A new epipen will be available soon for patients with severe emergency allergic reactions. For more information on the drug, read more.

After careful consideration, the FDA has requested that a particular opioid analgesic be removed from the market.

The US Food and Drug Administration has approved 3 formulations of a commonly prescribed antibiotic in injection form.

Aristada recently received approval from the US Food and Drug Administration for a new and shorter dosing regimen, providing more options to patients and health care providers.

The US Food and Drug Administration has expanded the approval of the Sapien 3 Transcatheter Heart Valve.

The FDA has approved a topical ocular formulation of a common antihistamine for the treatment of conjunctivitis.

The US Food and Drug Administration recently approved a new treatment option for patients with hemophilia B.

After successful results from a pivotal clinical trial, a new dosage for an integrase inhibitor was approved by the FDA.

The US Food and Drug Administration has approved a new generic option for the treatment of attention-deficit/hyperactivity disorder.